Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

Glyco-Biotic · Exploiting Microbial Glycomimetics to Fight Antimicrobial Resistance

HORIZONStatus: SIGNED1 September 202531 August 2027EU funding €260,348Call HORIZON-MSCA-2024-PF-01

Antimicrobial resistance (AMR) represents a significant health and economic challenge worldwide. Due to the fact that bacterial infections affect most people at some point in their lives, methods for specific recognition and targeting of bacteria are of key importance in developing approaches to counter the growth of AMR, where the discovery of novel antibiotics represents a global challenge in urinary tract infections (UTI). Progress in bioorganic synthesis has provided access to knowledge of the interactions between receptors (lectins) and specific carbohydrate on the outer membrane of bacteria. Cell surface carboAntimicrobial resistance (AMR) represents a significant health and economic challenge worldwide, where the discovery of novel antibiotics represents a global challenge in urinary tract infections (UTI). Progress in bioorganic synthesis has provided access to knowledge of the interactions between receptors (lectins) and specific carbohydrate on the outer membrane of bacteria. It is commonly accepted that this process requires an exquisite carbohydrate specificity of bacterial surface lectins and offer an opportunity to develop very selective probes that could target specific bacteria by the development of glycan mimics as potential drug candidates. Interestingly, some bacterial strains of E. coli are specific for galabiose. In order to design a drug candidate, it will be synthesized various glycomimetics with a common core of galabiose, which will be conjugated with a fluorescence probe to evaluate their binding affinity. Our hypothesis in this project resolves around the generation of a new class of antibiotics through the combination of known antibiotic drugs with the lead glycomimetics and allowing the drug delivery to the desired location. This project aims to test both aspects of the discovery of new antibiotics employing bioorganic approach based on the design, synthesis, diagnostic assays and drug delivery analysis of appropriate molecular models.

Consortium · 1 organisation

coordinator

UNIVERSITY OF BRISTOL

UK · €260,348

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.